Dillon Li

Rad Onc Resident @MSK_RadOnc | Studies DNA Damage, Cancer Immunity and Advanced RT Modalities | Tweets=Mine #ProtonBeam #FLASHRT

[Dillon Li @dillon_li]

Proud to review clinical evidence, ongoing trials and biological rationale for local ablative therapy in #oligomet #NSCLC with thought leaders @danielrgomez44 and @IyengarPuneeth. Looking forward to upcoming phase 3 trial results! https://t.co/Mq5tFYW0rl

[Dillon Li @dillon_li]

Our new study on nasopharyngeal cancer (NPC): proton therapy with IMPT for localized NPC is associated with fewer acute toxicities compared to standard of care IMRT, with local control rate of 100% at 2 years. @imrtlee @AnnaLeeMDMPH @MSK_RadOnc
https://t.co/YvzYYQyx20

[Dillon Li @dillon_li]

@icm2uk @MandyBrasherMD I was literally chanting cremasters!